Literature DB >> 24204068

Human papillomavirus (HPV) testing for normal cervical cytology in low-risk women aged 30-65 years by family physicians.

Maria Syl D de la Cruz1, Alisa P Young, Mack T Ruffin.   

Abstract

PURPOSE: The purpose of this study was to assess ordering of human papillomavirus (HPV) testing for normal cervical cytology among low-risk women aged 30 to 65 years.
METHODS: Audits of 833 cytology request forms for low-risk women completing a Papanicolaou smear, from January 2008 to April 2011, from 5 Michigan family medicine clinics determined HPV orders completed by the clinician performing the Papanicolaou smear. Multivariate logistic regression models examined differences in HPV test ordering by patient age at Papanicolaou test, provider status and sex, and clinic across sites. A Poisson regression model analyzed the annual number of HPV test orders over time.
RESULTS: Cytology requests were completed by 622 faculty (75%), 169 residents/fellows (20%), and 42 nurse practitioner/physician assistants (NP/PAs) (5%). HPV testing for any cytology result was ordered on 324 request forms (39%) by residents/fellows (48%), faculty (38%), and NP/PAs (10%). Female providers were twice as likely as men to order HPV testing for any cytology result across all clinics and provider statuses (P < .001). There were significant differences in HPV test ordering among clinics. Between 2008 and 2011 annual cytology requests increased 46%, including HPV testing for any cytology result after adjusting for faculty provider sex.
CONCLUSION: HPV test ordering when cytology is collected varied by clinic and provider status and sex. HPV co-testing for any cytology result remains modest, but is increasing over time in these clinics.

Entities:  

Keywords:  Diagnostic Use; Human Papilloma Virus DNA Probes; Mass Screening; Vaginal Smears

Mesh:

Substances:

Year:  2013        PMID: 24204068      PMCID: PMC4762362          DOI: 10.3122/jabfm.2013.06.120260

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  8 in total

1.  Cervical cytology screening practices among obstetrician-gynecologists.

Authors:  Kenneth L Noller; Barbara Bettes; Stanley Zinberg; Jay Schulkin
Journal:  Obstet Gynecol       Date:  2003-08       Impact factor: 7.661

2.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

3.  Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?

Authors:  Mona Saraiya; Zahava Berkowitz; K Robin Yabroff; Louise Wideroff; Sarah Kobrin; Vicki Benard
Journal:  Arch Intern Med       Date:  2010-06-14

4.  Association between physician specialty and uptake of new medical technologies: HPV tests in Florida Medicaid.

Authors:  Rebecca Anhang Price
Journal:  J Gen Intern Med       Date:  2010-06-26       Impact factor: 5.128

5.  Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-06-19       Impact factor: 25.391

6.  Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory.

Authors:  Darcy F Phelan; John K Boitnott; Douglas P Clark; Lisa C Dubay; Patti E Gravitt
Journal:  Obstet Gynecol       Date:  2011-08       Impact factor: 7.661

7.  Current cervical neoplasia screening practices of obstetrician/gynecologists in the US.

Authors:  Mona Saint; Ginny Gildengorin; George F Sawaya
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

8.  Use of DNA tests for human Papillomavirus infection by US clinicians, 2004.

Authors:  Nidhi Jain; Kathleen Irwin; Linda Carlin; Crystal Freeman; Daniel Montano; Danuta Kasprzyk
Journal:  J Infect Dis       Date:  2007-05-17       Impact factor: 5.226

  8 in total
  1 in total

1.  Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women.

Authors:  Adana A M Llanos; Jennifer Tsui; David Rotter; Lindsey Toler; Antoinette M Stroup
Journal:  BMC Womens Health       Date:  2018-10-03       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.